Library

Librarymckinleymedia2019-01-09T05:50:19-08:00

2019 AACR-NCI-EORTC (ANE) Molecular Targets: A comprehensive, highly a...

2019 SITC: Comprehensive and accurate prediction of presented neoantig...

2019 SITC: T-cell receptor alpha and beta repertoire profiling using a...

2019 SITC: Comprehensive profiling of tumor-immune interaction in anti...

Biomarker Challenge #2: Analysis of Complex Data

Biomarker Challenge #1: Limited Samples

2019 AACR: Applying immunopeptidomics and machine learning to improve ...

2019 AACR: A comprehensive, highly accurate genomics platform for prec...

2019 AACR: T-cell receptor repertoire profiling using an augmented tra...

2019 AACR: Development and validation of an accurate exome-scale cfDNA...

2019 AACR: Sensitive detection of oncoviruses integrated into a compre...

RepertoireID data sheet

2018 SITC: More sensitive identification of T-cell receptor beta rearr...

When an Exome Test Is Part of the Therapy and Not a Diagnostic: John W...

2018 SITC: Improving Neoantigen Identification for Therapeutic and Dia...

2018 AACR: Methods of Improving Accuracy of Neoantigen Identification...

2018 AACR: Supporting Neoantigen Discovery and Monitoring in Plasma Th...

2018 AACR: Molecular Profiling of Anti-PD-1 Treated Melanoma Patients ...

2018 AACR: Deconvolution of Diverse Immune Cell Populations within Tum...

NeoantigenID Data Sheet – An analytical module of the ImmunoID N...

ImmunogenomicsID Data Sheet – An analytical module of the Immuno...

ImmunoID NeXT brochure

Xtalks Webinar: Neoantigens for Personalized Cancer Vaccines-Comprehen...

ACE ImmunoID for Biomarker Discovery

Xtalks webinar: Overcoming the Challenges of Immuno-Oncology Biomarker...

Oncology Research Services

ACE ImmunoID

ACE ImmunoID: End-to-End Neoantigen Discovery

NeoantigenID

ImmunogenomicsID™

The Fight Against Cancer: Neoantigens, Tumor Escape and the Tumor Micr...

Getting cancer vaccines right: Key challenges and solutions for neoant...

Biomarker Discovery Solutions

Genomics Solutions for Neoantigen Vaccines

Symphony Genomics Workflow Management System: Managing, Integrating, ...

AMP Webinar: Comprehensive Tumor Characterization Using Augmented NGS

2017 AACR: Accurately Identifying Neoantigens Utilizing Both DNA and R...

2017 AACR: Supporting Neoantigen Identification for Personalized Cance...

2017 AACR: Comparative Analysis Of Multiple Copy Number Alteration Too...

2017 AACR: Supporting Neoantigen Identification for Personalized Cance...

2017 ASCO: Validation of an Expanded Neoantigen Identication Platform ...

2016 AACR-JCA: When Detecting Somatic Variants in Cancer Genomes, Is i...

2016 USCAP: Effects of formalin fixation variables on DNA integrity fo...

2016 USCAP: Validation of a Clinical 1400-Gene Assay for Genomic Profi...

2016 ACMG: Genome-wide copy-number detection using a hybrid clinical N...

2016 ACMG: Risk Assessment and Quality Plans for Next-Generation Seque...

How we ‘ACE’ Exome Sequencing

Comprehensive Tumor Characterization for Immuno Oncology, Clinical Tri...

ACE Augmentation Achieves High-Sensitivity for Clinical Applications

AMP Webinar: Achieving High Diagnostic Yield for Clinically Relevant G...

Labroots: ACE CancerPlus Test for DNA & RNA Sequencing for Improv...

Labroots: Benefits & Burdens of Assaying Matched Normal Tissue wh...

Introduction to Personalis

NGS-based Tumor Profiling: Lab, Clinic & Patient Perspectives

Tumor Characterization Solutions for Clinical Trials, Cancer Research ...

NGS Best Practices for Developing Personalized Neoantigen Vaccines

Labroots: Precision Genomics and Precision Medicine for Immuno Oncolog...

Maximizing Data Yield from FFPE Specimens

Find the answers to the most complex biological questions, with augmen...

Unlocking the potential of personalized neoantigen vaccines with ACE I...

Understanding the drivers of beneficial patient response with ACE Immu...

Precision Genomics for Precision Medicine: Examples in Immuno-Oncology

2016 AACR: Fix the Fixation: Effect of Formalin Fixation on Targeted S...

2016 AMP: Integration of Risk Assessment Strategies and Quality Contro...

2016 ACMG: Challenges in variant annotation for clinical genomic testi...

2016 AACR: Accurately Identifying Expressed Somatic Variants for Neoan...

2016 AACR: Answering the Challenge of Cancer Genetic Testing

2016 AACR: The benefits and burdens of assaying matched normal tissue ...

2016 AACR: Challenges in variant search and annotation for clinical ca...

2016 ASHG: In Silico Variant Effect Prediction for Whole Exome Analysi...

2016 CIMT: Validation of a Clinical 1400-Gene Assay for Genomic Profil...

2016 EORTA: Analytical validation of comprehensive assays for genomic ...

2016 AMP: Study of Visual Review and Sanger Confirmation Outcomes in E...

2016 ASCO: Effect of Assaying the Matched Normal on Clinical Cancer Se...

2016 ENA: Analytical validation of comprehensive assays for genomic pr...

2016 NSGC: Diagnosis of X-linked intellectual disability in an adult f...

What is Genome-Guided Medicine?

2015 AGBT: Challenges of Moving a Clinical Lab to GRCh38

2015 AGBT: An Augmented, Extended Cancer Gene Panel Integrating DNA an...

2015 ACMG: Towards Clinical-grade Detection, Annotation, and Interpret...

2015 ACMG: Use of an Augmented Exome for Disorders with High Genetic H...

2015 ACMG: Detection of Mosaicism by Augmented Exome Sequencing

2015 AACR: Solving Genomic Assay Trade-offs with an Optimized, Extende...

2015 AACR: Integrating RNA/DNA Analysis with a Comprehensive Cancer Pa...

2015 AACR: Genomic Characterization of a PDX Model of T-DM1-resistant ...

2015 ASHG: Comprehensive Genomic Characterization of Three Spatially a...

2015 ASHG: Effect of Formalin Fixation on Targeted DNA Sequencing and ...

2015 ASHG: Comparing Gene Panel and Augmented Exome Tests Using a Gold...

2015 ASHG: Challenges in variant annotation for clinical genomic testi...

2015 ASHG: Flying Blind: Building a Cancer Genomic Standard

2015 NSGC: Comparing Gene Panel and Augmented Exome Tests Using a “Gol...

2015 Genome informatics: CNVThresher: Combining multiple lines of evid...

2014 AACR: Creating and Accurately Interpreting Clinical-grade Cancer ...

2014 PGMG: Reinterpreting Variation in Light of GRCh38

2014 NSGC: Use of an Enhanced Exome with Genome-Wide Structural Varian...

2014 NSGC: Successful Utilization of Enhanced Exome Sequencing to Iden...

2014 NSGC: Homocystinuria Diagnosed by Whole Exome Sequencing in Sibli...

2014 NSGC: A Negative Result on Exome Sequencing: What a Genetic Coun...

2014 ICCG: The Clinical Exome: Personalis’ Experience Using an Enhance...

2014 ICCG: Impacts of Updating the Reference Assembly on Genome Interp...

2014 ICCG: 10 Common Misconceptions in Clinical NGS Sequencing

2014 Genome Informatics: Challenges of Migrating to GRCh38

2014 ASHG: Using an Augmented Exome to Improve Diagnostic Yield: Case ...

2014 ASHG: Integrated Analysis of Transcriptomes and Exomes in Cancer ...

2014 ASHG: Implementing an Augmented Clinical Exome and Reference Impr...

2014 ASHG: Accurate Detection of Low-representation Alleles in Tumor D...

2014 AMP: The ACE Clinical Exome: An Augmented Exome Providing Accurat...

2014 ACMG: User-Friendly Genomic Results: Leveraging a Novel Approach ...

2014 ACMG: Successes using ACE Exome Sequencing to Identify the Geneti...

2014 ACMG: Impacts of updating the reference assembly on genome interp...

2014 ACMG: Exome Sequencing in 20 Probands with Developmental Eye Defe...

2013 NSGC: Disease Diagnosis by Exome Sequencing: Issues Hampering Cau...

2013 ASHG: The Genetic Landscape of Moyamoya Disease in a Multi-Ethnic...

2013 ASHG: Recognition of disease-associated alleles in the reference ...